Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods of treating cancer with a combination of selected MEK1/2 and AXL inhibitors

Methods of treating cancer with a combination of selected MEK1/2 and AXL inhibitors

US Patent 10028958 · Granted Jul 24, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Synthetic hydrogels for organogenesis2024
Modular organ microphysiological system with integrated pumping, leveling, and s2023
Compositions and multiplex assays for characterizing active proteases and their 2022
Compositions and multiplex assays for characterizing active proteases and their 2022
Compositions and multiplex assays for characterizing active proteases and their 2022
Methods involving MenaINV in screening for inhibitors of cancer invasion and met2021
Methods involving MenaINV in screening for inhibitors of cancer invasion and met2021
Methods involving MenaINV in screening for inhibitors of cancer invasion and met2021
Modular platform for tissue integrated cell culture2021
Modular organ microphysiological system with integrated pumping, leveling, and s2020
Methods for identifying and treating invasive/metastatic breast cancers2019
Tricalcium phosphate binding peptides and uses thereof2019